Suppr超能文献

肝脏和肠道中用于胆固醇合成的乙酰辅酶A存在不同同位素富集的证据:静脉注射[13C]乙酸盐后大鼠的质量碎片分析法研究

Evidence for different isotopic enrichments of acetyl-CoA used for cholesterol synthesis in the liver and intestine: a study in the rat by mass fragmentography after intravenous infusion of [13C]acetate.

作者信息

Férézou J, Sulpice J C, Lutton C

出版信息

Biochim Biophys Acta. 1986 Feb 12;875(2):227-35. doi: 10.1016/0005-2760(86)90172-4.

Abstract

Wistar rats were killed 4 h after an intravenous infusion of [1,2-13C]- and [1-14C]acetic acid sodium salt (39 mg, 12.5 microCi/ml, constant rate: 1.2 ml/h). At this time, labeled free cholesterol movements between the organs are still weak and cholesterol labeling in each tissue mainly originates from the in situ incorporation of the exogenous substrate. In male rats, the specific radioactivity of free cholesterol was found to be higher in the intestine (mucosa and wall) than in the liver and plasma. In female and in cholestyramine-fed male rats, cholesterol 14C labeling was close to that of male rats in the intestine, and was markedly higher in the liver. The same variations of 13C excess, calculated by mass fragmentography, indicated that there was no isotopic effect between 13C and 14C precursors. The advantage of this method consisted in obtaining the proportions of labeled molecules according to their molecular weight (M + 1-M + 11) for each sample. Then the distribution of 13C atoms in newly synthesized cholesterol was assessed in each sterogenesis site. In the intestine, about 3/4 of the 13C atoms were found in molecules of weight of at least M + 4 (after incorporation of at least two labeled acetate units). This proportion was only 1/3 in hepatic and plasma free cholesterol. These distinct 13C-labeling patterns clearly indicate that local variations occurred in the isotopic enrichment of acetyl-CoA used for cholesterol formation. Whatever the experimental conditions of this study, cholesterol was synthesized from an acetyl-CoA more 13C enriched in the intestine than in the liver. Such variations probably result from the different dilutions of exogenous acetyl-CoA by the endogenous pool in the liver and intestine. Consequently, the 14C or 13C incorporations measured in the liver and intestinal sterols do not account for absolute rates of cholesterol production by these organs. This study also indicated that after a few hours of infusion, free cholesterol labeling in the plasma originated mainly from cholesterol newly formed in the liver, even when acetate incorporation into cholesterol was higher in the intestine than in the liver.

摘要

在静脉输注[1,2 - 13C] - 和[1 - 14C]乙酸钠盐(39毫克,12.5微居里/毫升,恒定速率:1.2毫升/小时)4小时后处死Wistar大鼠。此时,各器官间标记游离胆固醇的移动仍然较弱,各组织中的胆固醇标记主要源于外源性底物的原位掺入。在雄性大鼠中,发现肠道(黏膜和肠壁)中游离胆固醇的比放射性高于肝脏和血浆。在雌性大鼠以及喂食消胆胺的雄性大鼠中,肠道中胆固醇的14C标记与雄性大鼠相近,而在肝脏中则明显更高。通过质量碎片分析法计算得出的13C过量的相同变化表明,13C和14C前体之间不存在同位素效应。该方法的优势在于能够根据每个样品中标记分子的分子量(M + 1 - M + 11)获得其比例。然后在每个胆固醇生成部位评估新合成胆固醇中13C原子的分布。在肠道中,约3/4的13C原子存在于分子量至少为M + 4的分子中(在掺入至少两个标记的乙酸单位之后)。在肝脏和血浆游离胆固醇中,这一比例仅为1/3。这些明显不同的13C标记模式清楚地表明,用于胆固醇形成的乙酰辅酶A的同位素富集存在局部差异。无论本研究的实验条件如何,肠道中用于合成胆固醇的乙酰辅酶A比肝脏中的13C富集程度更高。这种差异可能是由于肝脏和肠道中内源性池对外源性乙酰辅酶A的不同稀释作用所致。因此,在肝脏和肠道固醇中测得的14C或13C掺入量并不能反映这些器官胆固醇产生的绝对速率。该研究还表明,输注数小时后,血浆中游离胆固醇的标记主要源于肝脏新生成的胆固醇,即使肠道中乙酸掺入胆固醇的量高于肝脏。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验